Faheem W Guirgis1, Christiaan Leeuwenburgh2, Victor Grijalva3, Jennifer Bowman1, Colleen Kalynych1, Lyle Moldawer4, Frederick A Moore4, Srinivasa T Reddy3. 1. Department of Emergency Medicine, College of Medicine, University of Florida, Jacksonville, Florida. 2. Institute on Aging, College of Medicine, University of Florida, Gainesville, Florida. 3. Department of Medicine, Molecular & Medical Pharmacology, UCLA, Los Angeles, California. 4. Department of Surgery, College of Medicine, University of Florida, Gainesville, Florida.
Abstract
BACKGROUND: Proper functioning of high-density lipoprotein (HDL) is necessary for protection against sepsis. However, previous work has demonstrated that HDL becomes oxidized and dysfunctional (Dys-HDL) during sepsis. Older (aged >65 years) patients are at particularly high risk of sepsis and poor outcomes from sepsis. STUDY OBJECTIVE: The aim of the study was to compare functional properties of HDL (cholesterol efflux capacity and paraoxonase enzyme 1 [PON-1] activity) and Dys-HDL between older (aged >65 years) sepsis patients and older healthy volunteers. METHODS: This was a subanalysis of a prospective study in which patients with sepsis were prospectively enrolled from the emergency department within the first 24 h. Serum and plasma samples were drawn from septic patients and age- and sex-matched control subjects. Percent cholesterol efflux, HDL inflammatory index, and PON1 activity were measured. Data were analyzed using Student t test or Wilcoxon rank-sum test. RESULTS: Ten sepsis and 10 healthy controls were analyzed. Mean age of sepsis patients (80 ± 2 years [SD]) and control subjects (77 ± 2 years) was similar (P = 0.31). Mean systolic blood pressures were significantly different in sepsis patients (113 ± 8 mmHg) compared with controls (133 ± 6 mmHg) (P = 0.049). Median SOFA scores for sepsis patients were 5.5 (interquartile range [IQR] 4-9). Mean percent cholesterol efflux was significantly reduced in sepsis (24.1 ± 1.2%) compared with controls (31.5 ± 1.0%) (P < 0.001). HDL inflammatory index was also significantly elevated in septic patients (1.63, IQR 1.3-2.34) compared with controls (0.62, IQR 0.56-0.67) (P < 0.001). However, PON1 activity was not significantly different between septic patients (70.3 ± 16.3 nmol/min/mL) and control subjects (88.8 ± 18.3 nmol/min/mL). CONCLUSIONS: Cholesterol efflux capacity seems to be significantly impaired in sepsis patients who also exhibited a higher index of Dys-HDL. The findings suggest that HDL function may be impaired in older individuals with sepsis.
BACKGROUND: Proper functioning of high-density lipoprotein (HDL) is necessary for protection against sepsis. However, previous work has demonstrated that HDL becomes oxidized and dysfunctional (Dys-HDL) during sepsis. Older (aged >65 years) patients are at particularly high risk of sepsis and poor outcomes from sepsis. STUDY OBJECTIVE: The aim of the study was to compare functional properties of HDL (cholesterol efflux capacity and paraoxonase enzyme 1 [PON-1] activity) and Dys-HDL between older (aged >65 years) sepsispatients and older healthy volunteers. METHODS: This was a subanalysis of a prospective study in which patients with sepsis were prospectively enrolled from the emergency department within the first 24 h. Serum and plasma samples were drawn from septic patients and age- and sex-matched control subjects. Percent cholesterol efflux, HDL inflammatory index, and PON1 activity were measured. Data were analyzed using Student t test or Wilcoxon rank-sum test. RESULTS: Ten sepsis and 10 healthy controls were analyzed. Mean age of sepsispatients (80 ± 2 years [SD]) and control subjects (77 ± 2 years) was similar (P = 0.31). Mean systolic blood pressures were significantly different in sepsispatients (113 ± 8 mmHg) compared with controls (133 ± 6 mmHg) (P = 0.049). Median SOFA scores for sepsispatients were 5.5 (interquartile range [IQR] 4-9). Mean percent cholesterol efflux was significantly reduced in sepsis (24.1 ± 1.2%) compared with controls (31.5 ± 1.0%) (P < 0.001). HDL inflammatory index was also significantly elevated in septic patients (1.63, IQR 1.3-2.34) compared with controls (0.62, IQR 0.56-0.67) (P < 0.001). However, PON1 activity was not significantly different between septic patients (70.3 ± 16.3 nmol/min/mL) and control subjects (88.8 ± 18.3 nmol/min/mL). CONCLUSIONS:Cholesterol efflux capacity seems to be significantly impaired in sepsispatients who also exhibited a higher index of Dys-HDL. The findings suggest that HDL function may be impaired in older individuals with sepsis.
Authors: Juan C Mira; Lori F Gentile; Brittany J Mathias; Philip A Efron; Scott C Brakenridge; Alicia M Mohr; Frederick A Moore; Lyle L Moldawer Journal: Crit Care Med Date: 2017-02 Impact factor: 7.598
Authors: M Navab; J A Berliner; G Subbanagounder; S Hama; A J Lusis; L W Castellani; S Reddy; D Shih; W Shi; A D Watson; B J Van Lenten; D Vora; A M Fogelman Journal: Arterioscler Thromb Vasc Biol Date: 2001-04 Impact factor: 8.311
Authors: William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub Journal: N Engl J Med Date: 2011-11-15 Impact factor: 91.245
Authors: Andrew J Murphy; Kevin J Woollard; Andreas Suhartoyo; Roslynn A Stirzaker; James Shaw; Dmitri Sviridov; Jaye P F Chin-Dusting Journal: Arterioscler Thromb Vasc Biol Date: 2011-04-07 Impact factor: 8.311
Authors: Lori F Gentile; Alex G Cuenca; Philip A Efron; Darwin Ang; Azra Bihorac; Bruce A McKinley; Lyle L Moldawer; Frederick A Moore Journal: J Trauma Acute Care Surg Date: 2012-06 Impact factor: 3.313
Authors: R Phillip Dellinger; John F Tomayko; Derek C Angus; Steven Opal; Michael A Cupo; Sharon McDermott; Annie Ducher; Thierry Calandra; Jonathan Cohen Journal: Crit Care Med Date: 2009-11 Impact factor: 7.598
Authors: Maureen McMahon; Jennifer Grossman; Brian Skaggs; John Fitzgerald; Lori Sahakian; Nagesh Ragavendra; Christina Charles-Schoeman; Karol Watson; Weng Kee Wong; Elizabeth Volkmann; Weiling Chen; Alan Gorn; George Karpouzas; Michael Weisman; Daniel J Wallace; Bevra H Hahn Journal: Arthritis Rheum Date: 2009-08
Authors: Lauren Page Black; Michael A Puskarich; Morgan Henson; Taylor Miller; Srinivasa T Reddy; Rosemarie Fernandez; Faheem W Guirgis Journal: J Intensive Care Med Date: 2020-06-24 Impact factor: 2.889
Authors: Faheem W Guirgis; Sunita Dodani; Christiaan Leeuwenburgh; Lyle Moldawer; Jennifer Bowman; Colleen Kalynych; Victor Grijalva; Srinivasa T Reddy; Alan E Jones; Frederick A Moore Journal: PLoS One Date: 2018-09-14 Impact factor: 3.240
Authors: Faheem W Guirgis; Lauren Page Black; Martin Daniel Rosenthal; Morgan Henson; Jason Ferreira; Christiaan Leeuwenburgh; Colleen Kalynych; Lyle L Moldawer; Taylor Miller; Lisa Jones; Marie Crandall; Srinivasa T Reddy; Samuel S Wu; Frederick A Moore Journal: BMJ Open Date: 2019-09-18 Impact factor: 2.692
Authors: Feng Su; Anantharamaiah Gm; Mayakonda N Palgunachari; C Roger White; Holly Stessman; Yanyuan Wu; Jay Vadgama; Richard Pietras; Dorothy Nguyen; Srinivasa T Reddy; Robin Farias-Eisner Journal: J Cancer Res Ther Oncol Date: 2020-01-17
Authors: Sébastien Tanaka; David Couret; Alexy Tran-Dinh; Jacques Duranteau; Philippe Montravers; Anna Schwendeman; Olivier Meilhac Journal: Crit Care Date: 2020-04-07 Impact factor: 9.097
Authors: Alexander C Reisinger; Max Schuller; Michael Holzer; Julia T Stadler; Gerald Hackl; Florian Posch; Gunther Marsche; Harald Sourij; Robert Ekart; Kathrin Eller; Philipp Eller Journal: Front Med (Lausanne) Date: 2020-10-22
Authors: Faheem W Guirgis; Lauren Page Black; Elizabeth DeVos; Morgan Henson; Jason Ferreira; Taylor Miller; Martin Rosenthal; Christiaan Leeuwenburgh; Colleen Kalynych; Lyle Moldawer; Lisa Jones; Marie Crandall; Srinivasa T Reddy; Hanzhi Gao; Sam Wu; Frederick Moore Journal: J Am Coll Emerg Physicians Open Date: 2020-11-18